Tazemetostat
1403254-99-8
572.7
C34H44N4O4
DMF, DMSO, Ethanol
-20°C
EPZ-6438 is an inhibitor of EZH2, a histone methyltransferase (HMT) responsible for methylation of lysine and arginine residues and controls gene transcription fidelity in cells. EPZ-6438 displays anticancer chemotherapeutic activity in in vivo models by inducing regression of malignant or atypical teratoid rhabdoid tumors containing altered or mutant SWI/SNF ATP-dependent chromatin remodelers.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
